Infant Bacterial Therapeutics AB OMXSTO:IBT_B:
Q4 OPERATING INCOME KSEK -20,538* (-37,445)
Infant Bacterial Therapeutics Q4 Operating Loss SEK 20.5 Mln
Earlier from Infant Bacterial Therapeutics Ab Class B
- Infant Bacterial Therapeutics Secures Partnership For Production Of Drug Product
- Infant Bacterial Therapeutics Secures Partnership For Production Of Drug Substance
- Infant Bacterial Therapeutics Q3 Operating Loss SEK 48.5 Mln
- Infant Bacterial Therapeutics AB: Quarterly Trading Report 2025 Q3